BioAge Labs
BIOA· Manufacturing· Fiscal year ends in December
CEO pay in FY2023
Kristen Fortney, Ph.D. is the CEO of BioAge Labs and was paid $1.4M in FY2023 (Dec).
PayNo stock prices for these years
Executives3
See all- 1Kristen Fortney, Ph.D.Chief Executive Officer and PresidentFY2023
- 2Eric Morgen, M.D.Chief Operating OfficerFY2023
- 3Paul Rubin, M.D.Chief Medical OfficerFY2023
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allBioAge Labs paid its 3 named executives $3.1M in total in FY2023 (Dec). CEO Kristen Fortney, Ph.D. was paid $1.4M of that.
| Name | |
|---|---|
| Kristen Fortney, Ph.D.Chief Executive Officer and President | |
| Eric Morgen, M.D.Chief Operating Officer | |
| Paul Rubin, M.D.Chief Medical Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for BioAge Labs. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board2
See all- Vijay PandeDirector · 8 yr on the boardIndependentAudit—Paid as an executive
- Michael DavidsonDirector · 1 yr on the boardIndependentCompensation (Chair), Nominating and Governance (Chair)—Paid as an executive
The board of the latest proxy (FY2025).
Activity
No new filings about this company in the feed.
Filings4
See all| Proxy statement | DEF 14A | Apr 21, 2026 | FY2025 |
| Annual report | 10-K | Mar 24, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 17, 2025 | FY2024 |
| Annual report | 10-K | Mar 20, 2025 | FY2024 |
